The International Institute of Molecular and Cell Biology in Warsaw (IIMCB) has officially joined EU-LIFE as part of the process of expansion of the alliance. The decision was ratified by the EU-LIFE Board of Directors and the IIMCB Director and is effective as of January 1, 2020.
The EU-LIFE alliance was composed of 13 leading research centres in life sciences from 13 European countries since its creation in 2013. By welcoming this 14th, Polish member, the alliance broadens its geographical spread to keep advocating for excellent research in Europe.
The EU-LIFE Board of Directors considered the IIMCB was perfectly fulfilling the EU-LIFE eligibility and selection criteria as this independent Polish institute is both a nationally and internationally recognised leading organisation striving for research excellence and best practices. "We are pleased to welcome a partner that actively shares our values, our commitment to excellence in research, and is engaged to act as an open and constructive member of the EU-LIFE alliance – and is enthusiastic about the collaborative possibilities offered by the EU-LIFE alliance," said EU-LIFE’s Chair Rene Medema. Moreover, this new membership will enrich the alliance regarding understanding of challenges faced by research entities in Central & Eastern Europe.
Welcoming the decision, Professor Marta Miączyńska, Director of the International Institute of Molecular and Cell Biology in Warsaw, said: "IIMCB strives for constant development towards excellence in research for the benefit of society. We are honoured to join the EU-LIFE alliance sharing the same values and to speak with one voice on issues related to the European science policies, to work on improving the quality of research and to share and draw on our mutual experience." "Joining the EU-LIFE alliance will help and inspire us in an exciting phase of growth of our institution" Professor Miączyńska underlined.
EU-LIFE is an alliance of research centres whose mission is to support and strengthen European research excellence. EU-LIFE members are leading research institutes in their countries and internationally renowned for producing excellent research, widely transferring knowledge and nurturing talent. Since its foundation in 2013, EU-LIFE has become a stakeholder in European policy participating regularly in the EU policy dialogue.
The EU-LIFE alliance unites European research institutes’ forces working on excellence in the life sciences, giving high regard to responsible science – such as assuring a good gender balance in science, promoting inclusive and diverse environments, career development and fair assessment of research within the European research area. The other central mission of EU-LIFE is to contribute to the European research agenda with a special attention to the European Research Area and Horizon Europe, the new European framework programme for research and innovation (2021–2027), for which preparations are in full swing. EU-LIFE has been advocating for a doubling of the R&I budget with respect to the current programme, Horizon 2020.
Center for Genomic Regulation (CRG, Spain) | Central European Institute of Technology (CEITEC, Czech Republic) | European Institute of Oncology (IEO, Italy) | Flanders Institute For Biotechnology (VIB, Belgium) | Friedrich Miescher Institute for Biomedical Research (FMI, Switzerland) | Institut Curie (France) | Institute for Molecular Medicine Finland (FIMM, Finland) | Instituto Gulbenkian de Ciência (IGC, Portugal) | International Institute of Molecular and Cell Biology in Warsaw (IIMCB, Poland) | Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC, Germany) | Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM, Austria) | The Babraham Institute (Babraham, United Kingdom) | The Netherlands Cancer Institute (NKI, The Netherlands) | The University of Copenhagen Biotech Research & Innovation Centre (BRIC, Denmark)